Aurobindo Pharma Ltd
NSE:AUROPHARMA
Aurobindo Pharma Ltd
NSE:AUROPHARMA
Price:
1 229.1
INR
0.29%
Market Closed
Market Cap:
₹713.9B
Balance Sheet
Balance Sheet Decomposition
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd
Balance Sheet Decomposition is not available for
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd
Balance Sheet
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd
Currency: INR
| Mar-2002 | Mar-2003 | Mar-2004 | Mar-2005 | Mar-2006 | Mar-2007 | Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
316
|
498
|
623
|
594
|
2 019
|
5 825
|
287
|
972
|
443
|
652
|
651
|
2 020
|
1 472
|
4 399
|
7 890
|
4 878
|
12 141
|
18 837
|
27 637
|
53 735
|
41 625
|
43 963
|
33 935
|
55 690
|
|
| Cash |
316
|
498
|
623
|
594
|
2 019
|
5 825
|
287
|
972
|
443
|
652
|
651
|
2 020
|
1 472
|
4 245
|
7 596
|
4 649
|
11 824
|
16 246
|
26 365
|
53 728
|
35 328
|
16 666
|
12 826
|
26 494
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
154
|
294
|
229
|
317
|
2 591
|
1 272
|
7
|
6 297
|
27 297
|
21 109
|
29 196
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
2 539
|
275
|
280
|
1 210
|
223
|
40
|
296
|
267
|
113
|
180
|
450
|
692
|
704
|
2 477
|
3 951
|
18 364
|
29 329
|
26 323
|
|
| Total Receivables |
5 026
|
5 176
|
5 770
|
5 838
|
7 819
|
8 981
|
8 795
|
11 226
|
12 043
|
15 718
|
15 334
|
16 873
|
30 071
|
36 937
|
46 574
|
35 419
|
50 575
|
61 231
|
58 705
|
50 594
|
58 889
|
66 871
|
76 258
|
83 743
|
|
| Accounts Receivables |
3 909
|
4 348
|
4 777
|
4 533
|
5 822
|
6 261
|
6 650
|
8 898
|
9 560
|
12 310
|
435
|
373
|
26 366
|
35 372
|
46 067
|
27 653
|
30 802
|
34 138
|
43 152
|
35 033
|
40 123
|
46 535
|
50 364
|
58 740
|
|
| Other Receivables |
1 117
|
828
|
993
|
1 305
|
1 997
|
2 720
|
2 145
|
2 328
|
2 483
|
3 408
|
14 899
|
16 500
|
3 705
|
1 565
|
507
|
7 766
|
19 773
|
27 093
|
15 553
|
15 561
|
18 766
|
20 336
|
25 894
|
25 004
|
|
| Inventory |
1 519
|
2 556
|
3 194
|
3 755
|
4 718
|
6 544
|
7 950
|
8 776
|
11 025
|
14 553
|
15 456
|
19 236
|
23 675
|
35 997
|
40 561
|
43 305
|
58 584
|
72 456
|
76 999
|
90 266
|
75 539
|
85 112
|
98 082
|
105 437
|
|
| Other Current Assets |
0
|
0
|
3
|
1
|
0
|
0
|
1 019
|
1 640
|
1 270
|
1 080
|
977
|
3 199
|
798
|
6 196
|
7 807
|
8 279
|
33
|
107
|
81
|
1 163
|
1 223
|
1 146
|
4 452
|
431
|
|
| Total Current Assets |
6 861
|
8 229
|
9 590
|
10 187
|
14 557
|
21 349
|
20 591
|
22 890
|
25 059
|
33 212
|
32 640
|
41 368
|
56 312
|
83 794
|
102 944
|
92 062
|
121 782
|
153 323
|
164 125
|
198 235
|
181 227
|
215 457
|
242 056
|
271 625
|
|
| PP&E Net |
2 645
|
7 239
|
8 670
|
10 572
|
11 492
|
12 750
|
14 316
|
18 371
|
21 688
|
22 054
|
25 872
|
26 386
|
28 068
|
31 986
|
42 163
|
53 204
|
61 361
|
70 356
|
81 166
|
93 155
|
106 660
|
124 918
|
142 849
|
154 554
|
|
| PP&E Gross |
2 645
|
7 239
|
8 670
|
10 572
|
11 492
|
12 750
|
14 316
|
18 371
|
21 688
|
22 054
|
25 872
|
26 386
|
28 068
|
0
|
42 163
|
53 204
|
61 361
|
70 356
|
81 166
|
93 155
|
106 660
|
124 918
|
142 849
|
154 554
|
|
| Accumulated Depreciation |
494
|
921
|
1 394
|
1 972
|
2 639
|
3 075
|
4 088
|
5 580
|
6 644
|
6 405
|
7 976
|
9 897
|
12 297
|
0
|
3 455
|
7 168
|
11 843
|
17 347
|
24 827
|
31 457
|
38 680
|
55 594
|
63 727
|
65 385
|
|
| Intangible Assets |
0
|
168
|
342
|
537
|
608
|
424
|
301
|
455
|
641
|
1 401
|
1 988
|
1 633
|
1 482
|
3 347
|
4 052
|
5 652
|
11 511
|
22 752
|
23 498
|
26 907
|
31 379
|
33 259
|
34 815
|
36 207
|
|
| Goodwill |
5
|
8
|
0
|
0
|
235
|
539
|
532
|
526
|
481
|
506
|
541
|
554
|
764
|
3 885
|
4 063
|
4 063
|
8 166
|
8 325
|
9 159
|
4 289
|
4 754
|
5 961
|
5 952
|
6 180
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 108
|
1 081
|
2 378
|
7 367
|
55
|
55
|
2 824
|
3 475
|
4 318
|
4 094
|
7 012
|
6 042
|
7 065
|
8 164
|
12 083
|
|
| Long-Term Investments |
165
|
12
|
2
|
2
|
3
|
3
|
604
|
3
|
3
|
385
|
199
|
222
|
198
|
1 030
|
1 765
|
2 459
|
3 115
|
3 602
|
5 547
|
4 312
|
6 183
|
3 917
|
3 217
|
2 517
|
|
| Other Long-Term Assets |
19
|
241
|
55
|
0
|
0
|
0
|
1
|
22
|
42
|
58
|
56
|
187
|
708
|
4 027
|
4 161
|
2 231
|
1 602
|
1 868
|
1 687
|
4 630
|
2 972
|
8 324
|
13 664
|
14 683
|
|
| Other Assets |
5
|
8
|
0
|
0
|
235
|
539
|
532
|
526
|
481
|
506
|
541
|
554
|
764
|
3 885
|
4 063
|
4 063
|
8 166
|
8 325
|
9 159
|
4 289
|
4 754
|
5 961
|
5 952
|
6 180
|
|
| Total Assets |
9 695
N/A
|
15 896
+64%
|
18 659
+17%
|
21 298
+14%
|
26 895
+26%
|
35 065
+30%
|
36 345
+4%
|
42 265
+16%
|
47 913
+13%
|
58 723
+23%
|
62 376
+6%
|
72 729
+17%
|
94 898
+30%
|
128 124
+35%
|
159 202
+24%
|
162 494
+2%
|
211 010
+30%
|
264 544
+25%
|
289 277
+9%
|
338 540
+17%
|
339 217
+0%
|
398 900
+18%
|
450 715
+13%
|
497 850
+10%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
1 431
|
2 346
|
2 252
|
2 903
|
3 861
|
4 205
|
4 679
|
5 148
|
6 044
|
7 764
|
6 601
|
9 638
|
13 512
|
20 392
|
24 570
|
21 547
|
23 729
|
25 522
|
25 761
|
27 947
|
27 031
|
38 713
|
44 542
|
41 889
|
|
| Accrued Liabilities |
14
|
14
|
12
|
10
|
33
|
21
|
25
|
21
|
0
|
47
|
105
|
117
|
117
|
87
|
45
|
523
|
1 105
|
1 322
|
904
|
903
|
1 626
|
2 076
|
3 463
|
2 463
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
58
|
66
|
104
|
116
|
137
|
12 347
|
16 082
|
22 361
|
23 546
|
24 971
|
36 727
|
29 027
|
40 313
|
65 575
|
54 223
|
48 027
|
21 236
|
41 647
|
40 781
|
53 097
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6 562
|
5 231
|
511
|
1 352
|
5 875
|
6 256
|
2 800
|
2 874
|
2 293
|
2 506
|
1 006
|
3 198
|
1 810
|
1 821
|
11 523
|
|
| Other Current Liabilities |
186
|
1 222
|
393
|
287
|
314
|
414
|
449
|
416
|
899
|
966
|
1 131
|
1 682
|
3 673
|
9 489
|
10 804
|
12 159
|
18 638
|
25 494
|
30 453
|
28 768
|
28 470
|
30 691
|
31 385
|
37 852
|
|
| Total Current Liabilities |
1 631
|
3 582
|
2 657
|
3 200
|
4 265
|
4 706
|
5 255
|
5 701
|
7 080
|
27 685
|
29 151
|
34 308
|
42 200
|
60 814
|
78 402
|
66 056
|
86 659
|
120 206
|
113 846
|
106 652
|
81 560
|
114 938
|
121 991
|
146 823
|
|
| Long-Term Debt |
4 265
|
6 965
|
8 231
|
10 340
|
13 731
|
20 781
|
19 059
|
23 283
|
21 490
|
5 234
|
9 646
|
11 483
|
12 794
|
13 111
|
7 428
|
1 814
|
4 512
|
1 800
|
2 644
|
4 887
|
5 678
|
9 405
|
23 874
|
18 009
|
|
| Deferred Income Tax |
219
|
360
|
521
|
613
|
726
|
682
|
733
|
790
|
954
|
1 234
|
39
|
680
|
2 054
|
2
|
240
|
493
|
2 353
|
2 813
|
2 917
|
5 746
|
4 110
|
3 896
|
3 566
|
3 033
|
|
| Minority Interest |
10
|
8
|
8
|
12
|
24
|
35
|
32
|
32
|
43
|
91
|
102
|
110
|
257
|
98
|
26
|
21
|
18
|
16
|
1
|
9
|
19
|
120
|
80
|
64
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
25
|
47
|
55
|
31
|
42
|
90
|
92
|
242
|
234
|
391
|
664
|
802
|
1 622
|
1 966
|
2 129
|
2 143
|
2 776
|
3 516
|
|
| Total Liabilities |
6 125
N/A
|
10 915
+78%
|
11 417
+5%
|
14 165
+24%
|
18 746
+32%
|
26 205
+40%
|
25 105
-4%
|
29 852
+19%
|
29 622
-1%
|
34 275
+16%
|
38 980
+14%
|
46 671
+20%
|
57 397
+23%
|
74 267
+29%
|
86 329
+16%
|
68 775
-20%
|
94 206
+37%
|
125 636
+33%
|
121 031
-4%
|
119 241
-1%
|
93 457
-22%
|
130 501
+40%
|
152 287
+17%
|
171 317
+12%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
207
|
233
|
254
|
254
|
267
|
267
|
269
|
269
|
279
|
291
|
291
|
291
|
292
|
292
|
585
|
586
|
586
|
586
|
586
|
586
|
586
|
586
|
586
|
581
|
|
| Retained Earnings |
3 011
|
3 823
|
4 775
|
4 641
|
5 095
|
6 929
|
9 108
|
9 827
|
15 138
|
20 089
|
18 516
|
20 946
|
31 651
|
49 294
|
67 928
|
89 571
|
111 158
|
133 303
|
159 465
|
210 408
|
234 230
|
249 573
|
278 483
|
306 816
|
|
| Additional Paid In Capital |
392
|
960
|
2 356
|
2 356
|
2 860
|
1 714
|
1 922
|
1 922
|
2 914
|
4 199
|
4 199
|
4 207
|
4 242
|
4 309
|
4 097
|
4 173
|
4 176
|
4 176
|
4 179
|
4 179
|
4 179
|
4 179
|
4 179
|
751
|
|
| Other Equity |
39
|
35
|
143
|
118
|
73
|
49
|
59
|
394
|
40
|
131
|
391
|
614
|
1 317
|
38
|
264
|
611
|
885
|
843
|
4 017
|
4 126
|
6 765
|
14 061
|
15 180
|
18 385
|
|
| Total Equity |
3 570
N/A
|
4 981
+40%
|
7 242
+45%
|
7 132
-2%
|
8 149
+14%
|
8 860
+9%
|
11 240
+27%
|
12 413
+10%
|
18 291
+47%
|
24 448
+34%
|
23 397
-4%
|
26 058
+11%
|
37 502
+44%
|
53 857
+44%
|
72 873
+35%
|
93 719
+29%
|
116 804
+25%
|
138 908
+19%
|
168 247
+21%
|
219 299
+30%
|
245 760
+12%
|
268 399
+9%
|
298 428
+11%
|
326 533
+9%
|
|
| Total Liabilities & Equity |
9 695
N/A
|
15 896
+64%
|
18 659
+17%
|
21 298
+14%
|
26 895
+26%
|
35 065
+30%
|
36 345
+4%
|
42 265
+16%
|
47 913
+13%
|
58 723
+23%
|
62 376
+6%
|
72 729
+17%
|
94 898
+30%
|
128 124
+35%
|
159 202
+24%
|
162 494
+2%
|
211 010
+30%
|
264 544
+25%
|
289 277
+9%
|
338 540
+17%
|
339 217
+0%
|
398 900
+18%
|
450 715
+13%
|
497 850
+10%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
413
|
465
|
508
|
508
|
533
|
533
|
538
|
538
|
557
|
582
|
582
|
582
|
583
|
584
|
585
|
586
|
586
|
586
|
586
|
586
|
586
|
586
|
586
|
581
|
|
Switch to:
Switch to:
See Also
Discover More
